Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells

Huntington's disease (HD) is a neurodegenerative condition characterized by pathology in the brain and peripheral tissues. Hyperactivity of the innate immune system, due in part to NFκB pathway dysregulation, is an early and active component of HD. Evidence suggests targeting immune disruption...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobson, Lucianne, Träger, Ulrike, Farmer, Ruth, Hayardeny, Liat, Loupe, Pippa, Hayden, Michael R., Tabrizi, Sarah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
HIGHLIGHTED ARTICLE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982105/
https://www.ncbi.nlm.nih.gov/pubmed/26823290
http://dx.doi.org/10.1111/jnc.13553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982105/
https://www.ncbi.nlm.nih.gov/pubmed/26823290
http://dx.doi.org/10.1111/jnc.13553

Ejemplares similares